Browsing ICR Divisions by author "Arlt, Volker Manfred"
Now showing items 1-5 of 5
-
Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy.
Arlt, VM; Pfohl-Leszkowicz, A; Cosyns, J; Schmeiser, HH (2001-07)Chinese herbs nephropathy (CHN), a unique type of nephropathy has been associated with the intake of weight-reducing pills containing the Chinese herb Aristolochia fangchi. Moreover, an association between the use of A. ... -
Comparison of activation of aristolochic acid I and II with NADPH:quinone oxidoreductase, sulphotransferases and N-acetyltranferases
Martinek, V; Kubickova, B; Arlt, VM; Frei, E; Schmeiser, HH; et al. (MAGHIRA & MAAS PUBLICATIONS, 2011)OBJECTIVES: Ingestion of aristolochic acid (AA) is associated with development of urothelial tumors linked with aristolochic acid nephropathy, and is implicated in the development of Balkan endemic nephropathy-associated ... -
DNA adduct formation and mutation induction by aristolochic acid in rat kidney and liver
Mei, N; Arlt, VM; Phillips, DH; Heflich, RH; Chen, T (ELSEVIER SCIENCE BV, 2006-12-01)Aristolochic acid (AA) is a potent nephrotoxin and carcinogen and is the causative factor for Chinese herb nephropathy. AA has been associated with the development of urothelial cancer in humans, and kidney and forestomach ... -
DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy.
Lord, GM; Hollstein, M; Arlt, VM; Roufosse, C; Pusey, CD; et al. (2004-04)Background Aristolochic acid-associated nephropathy (AAN) is a specific type of renal disease that predisposes patients to a high risk of urothelial carcinoma. The authors have analyzed DNA from a patient who had urothelial ... -
Metabolic activation of diesel exhaust carcinogens in primary and immortalized human TP53 knock-in (Hupki) mouse embryo fibroblasts
Kucab, JE; Phillips, DH; Arlt, VM (WILEY-BLACKWELL, 2012-04)Approximately 50% of human tumors have a mutation in TP53. The pattern and spectra of TP53 mutations often differ between cancer types, perhaps due to different etiological factors. The Hupki (human TP53 knock-in) mouse ...